Menu
← Oncology Approval Tracker
FDA DECISION ·
Bosutinib (Bosulif reference)
bosutinib monohydrate · Alembic Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic 100 mg and 500 mg tablets for adults with newly diagnosed chronic-phase Philadelphia chromosome-positive CML, or chronic-, accelerated-, or blast-phase disease resistant or intolerant to prior therapy.
LAMPGEN ANALYSIS
Why it matters
A generic tablet adds a potential source for BCR::ABL1 inhibition in chronic-phase CML.
What research teams should watch
Verify the available tablet strength and maintain molecular response, renal function, and adverse-event follow-up across products.
PRIMARY RECORDS